Dustin R. Abaonza
FDA Investigator
- Dustin R. Abaonza first started conducting FDA inspections in 2017, with the last inspection in 2024. Over that time, Dustin R. Abaonza has conducted 84 inspections at 79 companies across 81 sites.
Get Dustin Abaonza's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.
Documents
Upon purchase, you will receive an email with a link to immediately download the documents.
FDA 483 Genentech, Inc., South San Francisco | 2024
Out of stock
FDA 483 Mark Savant, M.D., San Francisco | 2024
Out of stock
FDA 483 Genentech, Inc., South San Francisco | 2024
Out of stock
FDA 483 Bay Area Tumor Institute IRB, Oakland | 2023
Out of stock
FDA 483 Pharmacyclics LLC, South San Francisco | 2022
Out of stock
FDA 483 John Muir Medical Center IRB #1, Concord | 2021
Out of stock
FDA 483 Adamas Pharmaceuticals, Inc., Emeryville | 2021
Out of stock
Co-Investigators (16)
- Sheilyn H. Huang, FDA Investigator
- Cynthia J. Tsui, FDA Investigator
- Linh Tu, FDA Investigator
- Kristin M. Abaonza, FDA Investigator
- Scott N. Lim, FDA Investigator
- Joan T. Briones, FDA Investigator
- Humberto Z. Gomez, FDA Investigator
- Yuanyuan Li, FDA Investigator
- Dustin P. Tran, FDA Investigator
- Cara L. Alfaro, FDA Investigator
- Diane C. Van Leeuwen, FDA Investigator
- Van Leeuwen, Diane C, FDA Investigator
- Stuart W. Russell, FDA Investigator
- Siobhan A. Gallagher, FDA Investigator
- Thomas N. Adjabeng, FDA Investigator
- Nympha V. Florendo, FDA Investigator